• admin@ataxiatelangiectasia.es
Atassia teleangectasia
  • Home
  • Cos'è l'A-T?
  • Notizia
  • Anti-peptide Antibody Responses in Patients with Ataxia-telangiectasia

  • Ataxia-telangiectasia: Immunodeficiency and survival.

  • Comparison of major lymphocyte subpopulations and recent thymic emigrants in patients with ataxia telangiectasia and age-matched healthy groups.

  • Dietary intakes and nutritional issues in inborn errors of immunity: a systematic review

  • Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle?

  • Evaluation of Specific Antibody Responses in Patients with Selective IgA Deficiency and Ataxia Telangiectasia

  • Minimum effective betamethasone dosage on the neurological phenotype in patients with ataxia-telangiectasia: a multicenter observer-blind study.

  • Newborn screening for SCID identifies patients with ataxia telangiectasia.

  • Progressive Depletion of B and T Lymphocytes in Patients with Ataxia Telangiectasia: Results of the Italian Primary Immunodeficiency Network

  • Reconstitution of the Ataxia-Telangiectasia Cellular Phenotype With Lentiviral Vectors.

  • Treatment of Granulomas in Patients With Ataxia Telangiectasia.

  • Two Novel Mutations Associated With Ataxia-Telangiectasia Identified Using an Ion AmpliSeq Inherited Disease Panel.

Language

Seleziona la tua lingua

  • Hindi (India)
  • Hebrew
  • Arabic (اللغة العربية)
  • Turkish (Turkey)
  • 日本語 (Japan)
  • Russian (Russia)
  • Français (France)
  • Deutsch (Deutschland)
  • Español (España)
  • Nederlands (nl-NL)
  • Português Brasileiro (pt-BR)
  • Polski (PL)
  • Italiano (Italia)
  • English (United Kingdom)

Tweets by A_Tinfo

  • Mappa del sito
Atassia teleangectasia
  • Home
  • Cos'è l'A-T?
  • Notizia
  • admin@ataxiatelangiectasia.es